[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA200000531A1 - Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом - Google Patents

Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом

Info

Publication number
EA200000531A1
EA200000531A1 EA200000531A EA200000531A EA200000531A1 EA 200000531 A1 EA200000531 A1 EA 200000531A1 EA 200000531 A EA200000531 A EA 200000531A EA 200000531 A EA200000531 A EA 200000531A EA 200000531 A1 EA200000531 A1 EA 200000531A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ketolides
atherosclerosis
prevention
complications associated
application
Prior art date
Application number
EA200000531A
Other languages
English (en)
Other versions
EA003322B1 (ru
Inventor
Франсис Пети
Франсуаз Вашерон
Original Assignee
Хехст Марион Руссель
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хехст Марион Руссель filed Critical Хехст Марион Руссель
Publication of EA200000531A1 publication Critical patent/EA200000531A1/ru
Publication of EA003322B1 publication Critical patent/EA003322B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Изобретение относится к новому терапевтическому применению кетолидов. В частности, изобретение относится к применению кетолидов для получения фармацевтических композиций, предназначенных для профилактики артериальных тромботических осложнений, связанных с атеросклерозом.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000531A 1997-11-17 1998-11-16 Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом EA003322B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
PCT/FR1998/002436 WO1999025365A1 (fr) 1997-11-17 1998-11-16 Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (2)

Publication Number Publication Date
EA200000531A1 true EA200000531A1 (ru) 2000-10-30
EA003322B1 EA003322B1 (ru) 2003-04-24

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000531A EA003322B1 (ru) 1997-11-17 1998-11-16 Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом

Country Status (35)

Country Link
US (1) US20080139489A1 (ru)
EP (1) EP1030673B1 (ru)
JP (1) JP4550273B2 (ru)
KR (1) KR20010032130A (ru)
CN (1) CN1286633A (ru)
AP (1) AP1196A (ru)
AR (1) AR014119A1 (ru)
AT (1) ATE271875T1 (ru)
AU (1) AU744419B2 (ru)
BG (1) BG104427A (ru)
BR (1) BR9814199A (ru)
CA (1) CA2312021C (ru)
DE (1) DE69825308T2 (ru)
DZ (1) DZ2654A1 (ru)
EA (1) EA003322B1 (ru)
EE (1) EE04095B1 (ru)
ES (1) ES2224446T3 (ru)
FR (1) FR2771008B1 (ru)
GE (1) GEP20032968B (ru)
HR (1) HRP20000314A2 (ru)
HU (1) HUP0004507A3 (ru)
ID (1) ID24940A (ru)
IL (1) IL136149A0 (ru)
MA (1) MA26566A1 (ru)
NO (1) NO20002435L (ru)
NZ (1) NZ504305A (ru)
OA (1) OA11411A (ru)
PL (1) PL340373A1 (ru)
SK (1) SK7042000A3 (ru)
TN (1) TNSN98206A1 (ru)
TR (1) TR200001384T2 (ru)
TW (1) TW472061B (ru)
WO (1) WO1999025365A1 (ru)
YU (1) YU29600A (ru)
ZA (1) ZA9810357B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
ATE344269T1 (de) 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
AU1675400A (en) * 1999-01-27 2000-08-18 Pfizer Products Inc. Ketolide antibiotics
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
ES2328109T3 (es) 2000-04-04 2009-11-10 Smithkline Beecham Plc Derivados de carbamato de 2-hihrosimutilina para uso antibacteriano.
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
US9815863B2 (en) * 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022819A1 (en) * 1991-06-14 1992-12-23 Board Of Regents Of The University Of Washington Diagnosis and treatment of arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
NO20002435D0 (no) 2000-05-11
CN1286633A (zh) 2001-03-07
CA2312021A1 (fr) 1999-05-27
BG104427A (en) 2001-02-28
DE69825308T2 (de) 2005-08-04
SK7042000A3 (en) 2000-12-11
EE04095B1 (et) 2003-08-15
TR200001384T2 (tr) 2001-06-21
KR20010032130A (ko) 2001-04-16
ID24940A (id) 2000-08-31
DE69825308D1 (de) 2004-09-02
HRP20000314A2 (en) 2001-02-28
PL340373A1 (en) 2001-01-29
AU1242599A (en) 1999-06-07
TW472061B (en) 2002-01-11
AU744419B2 (en) 2002-02-21
JP2001523644A (ja) 2001-11-27
AP2000001825A0 (en) 2000-06-30
OA11411A (fr) 2004-04-20
FR2771008B1 (fr) 2000-04-28
JP4550273B2 (ja) 2010-09-22
EP1030673B1 (fr) 2004-07-28
DZ2654A1 (fr) 2003-03-22
EP1030673A1 (fr) 2000-08-30
US20080139489A1 (en) 2008-06-12
YU29600A (sh) 2003-02-28
HUP0004507A3 (en) 2001-12-28
EA003322B1 (ru) 2003-04-24
IL136149A0 (en) 2001-05-20
ZA9810357B (en) 1999-11-12
NZ504305A (en) 2002-11-26
ES2224446T3 (es) 2005-03-01
HUP0004507A1 (hu) 2001-05-28
TNSN98206A1 (fr) 2005-03-15
GEP20032968B (en) 2003-05-27
FR2771008A1 (fr) 1999-05-21
WO1999025365A1 (fr) 1999-05-27
EE200000244A (et) 2001-06-15
AR014119A1 (es) 2001-02-07
MA26566A1 (fr) 2004-12-20
ATE271875T1 (de) 2004-08-15
AP1196A (en) 2003-08-18
CA2312021C (fr) 2008-08-26
BR9814199A (pt) 2000-09-26
NO20002435L (no) 2000-07-07

Similar Documents

Publication Publication Date Title
ES2189256T3 (es) Composiciones de mezclas de ester de cianoacrilato.
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
DK0915898T3 (da) Krystalform I af clarithromycin
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
IS5046A (is) Lyfjasamsetningar
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
DK1010374T3 (da) Fiberblanding til enterale sammensætninger
ID18352A (id) Komposisi-komposisi farmasi
DK0717041T3 (da) Krystallinske paclitaxel-hydrater
FI943569A0 (fi) Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia
IL114294A0 (en) Sterol derivatives
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
ES2173858T3 (es) Analogos de huperzina a.
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
DK0915819T3 (da) Illudinanaloger anvendt som antitumormiddel
YU11401A (sh) Lokalne farmaceutske kompozicije koje sadrže nimesulid
SE9801494D0 (sv) Novel use
EA200000531A1 (ru) Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
HN1998000045A (es) Composiciones farmaceuticas
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
DE69831737D1 (de) Neurotrypsin
ITRM950143V0 (it) Fermo per evitare la dilatazione di contenitori comprimibili, dopo la loro compressione.
IS2200B (is) Lyfjasamsetningar
ID27733A (id) Metoksiminofenilasetamida

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU